Surface Oncology - Stock Split History | SURF
Stock split history for Surface Oncology since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
|Surface Oncology Annual Stock Splits
|Surface Oncology Quarterly Stock Splits
||Medical Products Manufacturing
Surface Oncology, Inc. is a clinical-stage immuno-oncology company. It develops therapies for the treatment of cancer. The company's product pipeline includes CD47, CD73, SRF231, SRF373, SRF617, SRF388 and SRF231 which are in clinical stage. Surface Oncology is based in Cambridge, Massachusetts.